Switzerland-based Electro Medical Systems (EMS) and Hu-Friedy, a global leader in the manufacturing of dental instruments and products, announced a strategic alliance to deliver the most clinically advanced prophylaxis protocol to the U.S. and Canadian markets. The foundation of the strategic alliance is a focus on advancing prophylaxis protocol by leveraging Hu-Friedy’s heritage in high-quality hand instrumentation, coupled with best-in-class EMS offerings in Piezon scaling and air polishing.
With this new alliance, Hu-Friedy is now the exclusive U.S. and Canadian distributor of EMS Piezon® NO PAIN scaling technology, as well as AIR-FLOW® air polishing products. Combining these technologies with Hu-Friedy’s extensive line of hand scaling instruments offers clinicians access to the most comprehensive prophylaxis treatment methods, backed by legendary Hu-Friedy service and support.
While distribution is a key component of this strategic alliance, the partnership will extend into other areas including clinical education, evidence-based research and Key Opinion Leader partnerships.
In terms of the cultural fit of the alliance with EMS, Serota went on to state, “Hu-Friedy actively searched worldwide for a partner with similar values and a shared emphasis on helping clinicians perform at their best. With EMS, we have a partner who shares our commitment to innovation, quality and education.”
Also commenting on the synergies of the alliance, Antoine Preisig, CEO of EMS Dental said, “With nearly 140 years of combined experience, innovation and clinically proven products and processes, Hu-Friedy and EMS are perfectly situated to provide clinicians with the most effective, comfortable and economic prophylaxis protocol. EMS has a strong heritage of precision engineering and award-winning product design, which makes our state-of-the-art Piezon® scaling and AIR-FLOW® air polishing products the perfect complement to Hu-Friedy’s product portfolio. By leveraging the core competencies of both companies, we will fulfill our vision of bringing complete prophylaxis treatment to North America.”